OzBioPharm
Free Call 1 800 622 944
Navigation Menu Home Products Parkville Plant About Us Links
 

Product Line

Product Overviews

Product Labels

Product MSDSs

Product MIMS IVSs

Products
Reporcin MIMS IVS
 

Reporcin

IVS Product Listing 3964
Issue: March 2003 © 1996 - 2003 MIMS Australia
Alpharma Animal Health Pty Ltd
Section: 11 (d) Endocrine system - Trophic hormones
IVS Revision Date: 02 OCT 2003
Registered Name: Reporcin Porcine Somatotropin for Injection
Composition: Methionyl porcine somatotropin
Actions: In the finisher phase, natural somatotropin levels decrease, which results in fatter, less efficient pigs. Reporcin porcine somatotropin (pST) supplements the endogenous levels of porcine somatotropin to promote deposition of protein in growing pigs at the expense of fat. pST in combination with appropriate diets will decrease fat deposition, improve feed conversion efficiency, increase average daily weight gain and increase lean met yield.
Description: White to pale yellow powder.
Indications: pST supplements the endogenous levels of porcine somatotropin to promote deposition of protein in a growing pig at the expense of fat. pST will also enhance the conversion of feed by pigs into live weight gain and reduce the time taken to achieve a final weight. Maximum growth and feed conversion can be expected with the daily treatment regime.
Precautions:
1. Treat each animal for one 30 day period only. Do not repeat course of treatment.
2. Do not administer PST to selected breeding stock or pregnant or lactating sows. If gilts inadvertently treated with PST are retained for breeding, do not mate until 21 days after completion of the 30 day treatment period.
3. To achieve maximum benefits from PST , treated pigs should be fed diets which have at least the minimum lysine levels as recommended in the Feeding Standards for Australian Livestock Pigs (1987).
4. Do not exceed the weekly dose rate of 35 mg.
A condition of use of this preparation is that only the approved gas powered injection equipment is used by operators that have been trained to administer it.
Advice To Persons Injecting Livestock: CAUTION: AVOID CARCASS DAMAGE
Following the advice below will reduce the incidence of abscesses and other reactions caused by injection. Such reactions may be responsible for condemnation or downgrading of carcasses at slaughter. Although a number of these blemishes may be regarded as an inevitable consequence of mass injection programs, careful siting of injections will minimize their importance.
1. The approved injection equipment should be cleaned and sterilized after use and stored following the supplied instructions of the manufacturer N. J. Phillips. Maintain cleanliness at all times. Needles should be kept sharp and clean. Replace frequently. Use the standard gauge needles supplied to fit the approved injection equipment.
2. As far as possible, avoid injection during wet weather or in very dusty yards or on excessively soiled animals. Injections should be made only in the neck muscles.
3. Any injectable which becomes contaminated during use should be discarded.
Safety Directions: The product should be reconstituted in the vial supplied. During the reconstitution procedure care must be taken to prevent needle stick injury
Disposal: Dispose of empty containers, outer packaging or expired product by wrapping with paper and putting in garbage. Discarded needles should immediately be placed in a designated and appropriately labelled "sharps" container. The container should be of a type to reduce the possibility of injury to handlers during collection and disposal. Incineration is the preferred method of disposal, otherwise "sharps" should be buried at a suitable site, such as in a farm chemical disposal pit located away from watercourses.
Withholding Periods: MEAT: Nil
Dosage and Administration:
Directions For Use
A condition of use of this preparation is that only the approved gas powered injection equipment is used by operators that have been trained to administer it. The equipment and training are supplied by Alpharma Animal Health Pty. Ltd.
This product may be administered as a daily dose of 5 mg (equivalent to 35 mg/wk)
OR as a 10 mg dose on alternate days (bidaily) (equivalent to 35 mg/wk)
OR 3 x week -Monday Wednesday Friday (MWF) (equivalent to 30 mg/wk)
Reconstitution
The product should be reconstituted in the vial supplied. During the reconstitution procedure care must be taken to prevent needle stick injury.
Daily Treatment (5 mg dose): Diluent 20[40/60] mL should be drawn from the matching diluent pack and injected into the pST vial. The needle with syringe attached should remain in the pST vial until all the pST is dissolved to minimize contamination. The concentrated pST solution should then be withdrawn and injected into the 100[200/500] mL diluent pack, which is then ready for connection to the approved gas powered injection device.
Bi-daily and MWF Treatments (10 mg dose): Diluent 20[40/60] mL should be drawn from the matching diluent pack and injected into the pST vial. This should be repeated with a second pST vial. The needle with syringe attached should remain in the pST vial until all the pST is dissolved to minimize contamination. The concentrated pST solution should then be withdrawn from each vial and the contents of both injected into the diluent pack, which is then ready for connection to the approved gas powered injection device.
Dosage and Administration
The product should be injected into the muscle immediately behind the ear and not at any other site.
Daily Dose: A dose of 5 mg pST (1 mL of reconstituted product) is administered intramuscularly daily for 30 days corresponding to the "finishing" stage prior to slaughter.
Bi-daily Dose: A dose of 10 mg pST (1 mL of reconstituted product) is administered intramuscularly on alternate days for 30 days corresponding to the "finishing" stage prior to slaughter.
MWF Dose: A dose of 10 mg pST (1 mL of reconstituted product) is administered intramuscularly on Mondays, Wednesdays and Fridays for 30 days corresponding to the "finishing" stage prior to slaughter.
Presentation: pST vials containing the equivalent of 500/1000/2500 mg lyophilised Porcine Somatotropin + sterile diluent packs of 100/200/500 mL of purified water.
Storage: Store pST vials below 8oC (refrigerate). Reconstitute in pST vial. Once reconstituted, Reporcin solution should be stored at 8oC no longer than 48 hours. Store diluent packs below 30oC (room temperature).
Poison Schedule: NIL
Registration: All states
ACVM Number: 45984

End of IVS Product Listing 3694

Reporcin

IVS Product Listing 3965
Issue: March 2003 © 1996 - 2003 MIMS Australia
Alpharma Animal Health Pty Ltd
Section: 13 (g) Nutrition and metabolism - Growth Promotants
Registered Name: Reporcin Porcine Somatotropin for Injection
Composition: Methionyl porcine somatotropin
For further information see Reporcin, Section 11(d)

End of IVS Product Listing 3695

 
HOME  |  PRODUCTS  |  PARKVILLE PLANT  |  ABOUT US  |  LINKS
©Copyright 2006
OzBioPharm Pty Ltd all rights reserved